Brian O. Porter

5.1k citations
79 papers · 4.1k · 2 hit papers · h-index 34

Impact in

  • Rheumatology top 0.2%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
  • Immunology top 2%
    • Psoriasis: Treatment and Pathogenesis
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses

Papers in

    • Spondyloarthritis Studies and Treatments 39
    • Rheumatoid Arthritis Research and Therapies 11
    • Immune Cell Function and Interaction 9
    • T-cell and B-cell Immunology 8
    • Psoriasis: Treatment and Pathogenesis 6
    • Immunotherapy and Immune Responses 4

Brian O. Porter

77 papers receiving 4.0k citations

Brian O. Porter's Hit Papers

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data 2019 · 247 citations
2470+3+7Years since publication250500750

Peers

Brian O. Porter
Comparison fields: 5 of 113
  • Rheumatology 2.1k
  • Immunology 1.7k
  • Hematology 639
  • Virology 118
  • Dermatology 144
Replace José Luís Andreu with:
José Luís Andreu Spain
Bruce Freundlich United States
Fenglong Xie United States
Denis Mulleman France
Steve Hoffmann United States
Sampath Prahalad United States
Michael Frosch Germany
Ferry C Breedveld Netherlands
Anne Nicholls United Kingdom
Roberto Gorla Italy
Brian O. Porter relative to José Luís Andreu Spain José Luís Andreu's profile →
Citations per field
00.5×2×4×5.9×
José Luís Andreu · 1×
Citations per year

Countries citing papers authored by Brian O. Porter

Since Specialization
Citations

This map shows the geographic impact of Brian O. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian O. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian O. Porter more than expected).

Fields of papers citing papers by Brian O. Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian O. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian O. Porter. The network helps show where Brian O. Porter may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian O. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian O. Porter Line = papers co-authored together Brian O. Porter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Hit paper breakdown →
2015828
2
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Hit paper breakdown →
2019247
3 2017191
4 2010155
5 2019153
6 2016149
7 2000129
8 2020128
9 2018118
10 2018117
11 2014100
12 201899
13 201385
14 201784
15
Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial.
201878
16 201175
17 201671
18 201565
19 199957
20 199949

About Brian O. Porter

Brian O. Porter is a scholar working on Rheumatology, Immunology, Hematology, Emergency Medicine and Surgery, having authored 79 papers that have together received 4.1k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (39 papers), Rheumatoid Arthritis Research and Therapies (11 papers), Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (8 papers), Infectious Diseases and Tuberculosis (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Psoriasis: Treatment and Pathogenesis (6 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Rheumatology (2.1k citations), Immunology (1.7k citations), Hematology (639 citations), Virology (118 citations) and Dermatology (144 citations). Brian O. Porter has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Atul A. Deodhar, Xenofon Baraliakos, Hanno B. Richards, Thomas R. Malek, Jürgen Braun, Ruvie Martin, Mats Andersson, Joachim Sieper, Paul Emery and Dominique Baeten. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Research & Therapy, AIDS and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact